AGT and cardiac hypertrophy: This alternative model wherein MKL1 activates miR-155 transcription in cardiomyocytes to promote cardiac hypertrophy is certainly tempting in light of our recent report that cardiomyocyte-specific MKL1 deletion attenuates angiotensin II induced cardiac hypertrophy in mice (Wu et al., 2020).